Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;30(5):672-81.
doi: 10.1016/j.neurobiolaging.2007.08.019. Epub 2007 Oct 24.

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

Lidia Glodzik-Sobanska  1 , Elizabeth Pirraglia, Miroslaw Brys, Susan de Santi, Lisa Mosconi, Kenneth E Rich, Remigiusz Switalski, Leslie Saint Louis, Martin J Sadowski, Frank Martiniuk, Pankaj Mehta, Domenico Pratico, Raymond P Zinkowski, Kaj Blennow, Mony J de Leon
Affiliations

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

Lidia Glodzik-Sobanska et al. Neurobiol Aging. 2009 May.

Abstract

While cerebrospinal fluid (CSF) biomarkers are of use in the prediction and diagnosis of Alzheimer's disease our understanding of the background effects of age and the ApoE genotype is limited. Seventy-eight community-based normal volunteers (mean age 60+/-10 years, range 36-86) were examined to determine the relationships between CSF measures of total tau (T-tau), hyperphosphorylated tau (P-tau 231), amyloid beta (Abeta42/Abeta40 ratio), and isoprostane (IP) with age and ApoE genotype. The results showed that age by epsilon4 genotype interactions were found for P-tau231 (beta=1.82; p<0.05) and IP (beta=1.6; p<0.05). T-tau CSF concentration increased with age. The increasing CSF concentrations of P-tau and IP in epsilon4 carriers suggest that early tauopathy and oxidative stress may be related to the increased risk for AD. The data also suggest that T-tau changes are more age dependent than Abeta changes. The evidence that P-tau231 and IP are the earliest markers for the neuronal damage related to AD awaits longitudinal study.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
T-tau (A), P-tau231 (B), IP (C) concentrations and A β42/A β40 (D) in CSF as a function of age and ApoE genotype. Solid line: ε4 positive group; dashed line: ε4 negative group.
Fig. 2
Fig. 2
Significant correlations between CSF variables: (A) correlation between IP and Ttau; (B) correlation between IP and P-tau 231; (C) correlation between T-tau and Aβ42/Afj40; (D) correlation between P-tau231 and Aβ40/Aβ42; (E) correlation between T-tau and P-tau231.
See this image and copyright information in PMC

References

    1. Andreasen N, Vanmechelen E, Van d V, Davidsson P, Hesse C, Tarvonen S, Raiha I, Sourander L, Winblad B, Blennow K. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study. J. Neurol. Neurosurg Psychiatry. 1998;64:298–305. - PMC - PubMed
    1. Arai H, Morikawa Y, Higuchi M, Matsui T, Clark CM, Miura M, Machida N, Lee VM, Trojanowski JQ, Sasaki H. Cere-brospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys. Res. Commun. 1997;236:262–264. - PubMed
    1. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease. Acta Neuropatholog. 2002;103(1):26–35. - PubMed
    1. Bachman DL, Wolf MD, Linn R, Knoefel JE, Cobb J, Belanger BS, D’Agostino RB, White LR. Incidence of dementia and probable Alzheimer’s disease in a general population: the Framingham Study. Neurology. 1993;43:515–519. - PubMed
    1. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66(12):1837–1844. - PubMed

Publication types

MeSH terms